Stable Isotope Labelled Natalizumab Biosimilar – Anti-ITGA4/CD49d mAb – Research Grade

Reference: PX-TA1053-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Natalizumab Biosimilar - Anti-ITGA4/CD49d mAb - Research Grade
SourceCAS 189261-10-7
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsAN 100226,BG00002
ReferencePX-TA1053-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Natalizumab Biosimilar - Anti-ITGA4/CD49d mAb - Research Grade

General information on Anti-ITGA4/CD49d(Homo sapiens) (Natalizumab) Monoclonal Antibody

Natalizumab is a humanized monoclonal antibody produced in murine myeloma cells of isotype IgG4k. Natalizumab contains a human framework region and a complementarity determining region of a murine antibody that binds to ?4-integrin. Natalizumab has been temporarily discontinued due to the risk of progressive multifocal leukoencephalopathy (PML).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Natalizumab Biosimilar – Anti-ITGA4/CD49d mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products